(Q51603001)

8 April 2018

title

Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine. (English)

1 reference

8 April 2018

0 references

D-L Cao

1

1 reference

8 April 2018

D-W Ye

2

1 reference

8 April 2018

Y Zhu

3

1 reference

8 April 2018

H-L Zhang

4

1 reference

8 April 2018

Y-X Wang

5

1 reference

8 April 2018

X-D Yao

6

1 reference

8 April 2018

publication date

15 February 2011

1 reference

8 April 2018

Prostate Cancer and Prostatic Diseases

published in

1 reference

8 April 2018

volume

14

1 reference

8 April 2018

issue

2

1 reference

8 April 2018

page(s)

166-172

1 reference

8 April 2018

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Changing demography of prostate cancer in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Clinical applications of metabolomics in oncology: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Metabolic profiles of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Urine metabolomics analysis for kidney cancer detection and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Why and when channelling can decrease pool size at constant net flux in a simple dynamic channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Channelling can decrease pool size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Reply from Authors re: Jack A. Schalken. Is Urinary Sarcosine Useful to Identify Patients With Significant Prostate Cancer? The Trials and Tribulations of Biomarker Development. Eur Urol 2010;58:19–20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Reply to Arun Sreekumar, Laila M. Poisson, Thekkelnaycke M. Rajendiran, et al.’s Letter to the Editor re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Importance of sarcosine formation in methionine methyl carbon oxidation in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

Methyl balance and transmethylation fluxes in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.2

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.2

1 reference

8 April 2018

1 reference

8 April 2018